{"id":88207,"date":"2005-09-20T06:00:00","date_gmt":"2005-09-20T04:00:00","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/s4-dla-nowej-marki\/"},"modified":"2005-09-20T06:00:00","modified_gmt":"2005-09-20T04:00:00","slug":"s4-dla-nowej-marki","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/atl\/s4-dla-nowej-marki.html","title":{"rendered":"S4 dla nowej marki"},"content":{"rendered":"<p><P>W wyniku przetargu Novartis podpisa\u0142 z S4 bezterminow\u0105 umow\u0119 na obs\u0142ug\u0119 kampanii reklamowej leku Orofar. W konkursie Agencja pokona\u0142a trzech rywali: Marketing &amp; Media&nbsp;&#8211; agencj\u0119 odpowiedzialn\u0105 dot\u0105d za obs\u0142ug\u0119 reklamow\u0105 marki oraz Peppermint Medical i IQ Marketing. <\/P><br \/>\n<P>S4 zajmuje si\u0119 kreacj\u0105 z zakresu dzia\u0142a\u0144 BTL oraz ATL. Agencja ma za zadanie nie tylko wypromowanie nowej postaci leku, ale r\u00f3wnie\u017c rekomendacj\u0119 dost\u0119pnego ju\u017c na rynku leku Orofar w tabletkach dla doros\u0142ych. Za strategi\u0119 i kreacj\u0119 ca\u0142o\u015bci przedsi\u0119wzi\u0119cia odpowiada Michael Heidtman, team creative leader. <\/P><br \/>\n<P>Kampania, skierowana do lekarzy, farmaceut\u00f3w i pacjent\u00f3w, rozpocz\u0119\u0142a si\u0119 we wrze\u015bniu br. Media do kampanii planuje Media Edge: CIA<\/P><\/p>\n","protected":false},"excerpt":{"rendered":"Agencja Reklamowa S4 prowadzi kampani\u0119 promuj\u0105c\u0105 now\u0105 posta\u0107 leku Orofar &#8211; produkowanego  przez Novartis Poland Sp. z o.o.","protected":false},"author":1,"featured_media":88208,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9642],"tags":[],"class_list":{"0":"post-88207","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atl","8":"cs-entry","9":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/88207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=88207"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/88207\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/88208"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=88207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=88207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=88207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}